How Vitt was paid
$2.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Dr. Daniel VittChief Executive Officer | $625,250 | $1,043,081 | $401,258 | $100,000 | $2,302,889 |
| Dr. Duane D. NashFormer Executive Chairman | $400,551 | $368,505 | $162,000 | — | $979,881 |
| Dr. Andreas MuehlerFormer Chief Medical Officer | $540,125 | $400,696 | $252,274 | $17,426 | $1,261,671 |
| Glenn WhaleyChief Financial Officer | $463,750 | $337,093 | $218,500 | — | $1,062,743 |
| Jason TardioCOO and President | $512,500 | $400,696 | $239,200 | — | $1,203,546 |
What changed and why
- 2,302,889 was CEO Daniel Vitt's 2025 total compensation, down from 2,938,223 in 2024.
- 115%115% was the approved 2025 bonus payout for Vitt, Muehler, Whaley and Tardio.
- 133,300 in stock appreciation rights was reported for Vitt in 2025.
- 162,000 was paid to former Executive Chairman Duane Nash in addition to his listed compensation.
- 100,000 in other compensation for Vitt represented a housing allowance.
- June 1, 2026 marked Vitt's resignation as CEO and Erik Lundgren's start as successor.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.